Manager TitleAgeSince
Chief Executive Officer 58 2023-04-23
Director of Finance/CFO - 2024-10-30
Human Resources Officer 58 2015-08-31
Director TitleAgeSince
Chairman 53 2023-04-23
Director/Board Member 62 2018-05-10
Director/Board Member 73 2018-05-10
Date Insider Type Main position Quantity % Market Cap.
23-05-11
South Bay Ventures BV
BuyCompany 600,000 0.6419%
21-05-03
Marcofin BV
Fiscal yearCompany 30,000 0.0521%
21-05-03Free

Chairman

60,000 0.1043%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 31.4M
+0.03%+0.81%+28.16%-2.77% 12.52B
-0.73%-3.34%+62.77%+34.91% 6.06B
-1.55%+2.93%+7.32%+13.66% 5.8B
+0.52%+2.81% - - 4.32B
-4.84%-3.17%-36.50%+4.18% 3.84B
-1.74%-0.80%-27.12%-24.91% 3.82B
+2.31%+16.96%+4.91%-56.86% 2.05B
-0.78%+3.43%+27.05%+263.53% 1.87B
+0.94%+0.33%+57.48%-5.96% 1.52B
Average -0.59%+1.93%+15.51%+28.22% 4.65B
Weighted average by Cap. -0.76%+1.17%+18.14%+14.53%
Logo Biocartis Group NV
Biocartis Group NV specializes in the development of molecular diagnostic systems. Especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
Employees
500
  1. Stock Market
  2. Stocks
  3. BCART Stock